Completed PHASE2 INTERVENTIONAL 5-arm NCT00507936

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

A Global, Multicenter, Randomized, Double-Blind Placebo Controlled Study Comparing the Safety and Efficacy of ABT-894, Duloxetine and Placebo in Subjects With Diabetic Neuropathic Pain

Sponsor: AbbVie (prior sponsor, Abbott)

Conditions Diabetic Neuralgia Diabetic Neuropathies Diabetic Neuropathy, Painful Diabetic Polyneuropathy Neuralgia, Diabetic

Interventions ABT-894 Duloxetine placebo

Updated 8 times since 2017 Last updated: Jan 15, 2013 Started: Aug 31, 2007 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Diabetic Neuralgia and Diabetic Neuropathies and is currently completed. AbbVie (prior sponsor, Abbott) leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AbbVie (prior sponsor, Abbott)

Data source: AbbVie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anaheim, United States , Berlin, Germany , Brockton, United States , Cincinnati, United States , Clearwater, United States , Corbeil-Essonnes, France , Cuyahoga Falls, United States , Essen, Germany , Frankfurt, Germany , Garden Grove, United States and 32 more locations